Crown Grows With Keri From GSK, Which Says Little On Consumer Pending JV Launch With Pfizer

 
• By Malcolm Spicer
  
Crown Laboratories, Inc offices
Crown Labs lands North American rights to the Keri brand, its second deal with GSK in five months.
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Archive

More from HBW Insight